Immunoprecise Stock Volatility

IPA -  USA Stock  

USD 5.30  0.15  2.75%

Immunoprecise Antibodies appears to be moderately volatile, given 3 months investment horizon. Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of 0.0464, which attests that the entity had 0.0464% of return per unit of risk over the last 3 months. Our standpoint towards determining the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Immunoprecise Antibodies, which you can use to evaluate the future volatility of the firm. Please utilize Immunoprecise Antibodies' Risk Adjusted Performance of 0.0765, downside deviation of 4.13, and Market Risk Adjusted Performance of 0.2381 to validate if our risk estimates are consistent with your expectations.
  
Refresh
Immunoprecise Antibodies Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Immunoprecise daily returns, and it is calculated using variance and standard deviation. We also use Immunoprecise's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Immunoprecise Antibodies volatility.

720 Days Market Risk

Moderately volatile

Chance of Distress

Below Average

720 Days Economic Sensitivity

Almost mirrors the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Immunoprecise Antibodies can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Immunoprecise Antibodies at lower prices. For example, an investor can purchase Immunoprecise stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Immunoprecise Antibodies' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Immunoprecise Antibodies

0.84ARQTArcutis BiotherapeuticsPairCorr
0.79VRTXVertex PharmaceuticPairCorr
0.79NONOFNOVO NORDISK ASPairCorr
0.76TWTRTwitterPairCorr
0.75ADMAAdma BiologicsPairCorr
0.74NVONovo Nordisk ASPairCorr
0.74ADUSAddus Homecare CorpPairCorr

Moving against Immunoprecise Antibodies

-0.74AKBAAkebia TherapeuticsPairCorr
-0.7AMAMAmbrx BiopharmaPairCorr
-0.64ANNXAnnexonPairCorr
-0.61AFIBAcutus MedicalPairCorr
-0.57AMLXAmylyx PharmaceuticalsPairCorr
-0.56ABOSAcumen PharmaceuticalsPairCorr
-0.56APTXAptinyxPairCorr

Immunoprecise Antibodies Market Sensitivity And Downside Risk

Immunoprecise Antibodies' beta coefficient measures the volatility of Immunoprecise stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Immunoprecise stock's returns against your selected market. In other words, Immunoprecise Antibodies's beta of 1.01 provides an investor with an approximation of how much risk Immunoprecise Antibodies stock can potentially add to one of your existing portfolios.
Let's try to break down what Immunoprecise's beta means in this case. Immunoprecise Antibodies returns are very sensitive to returns on the market. As the market goes up or down, Immunoprecise Antibodies is expected to follow.
3 Months Beta |Analyze Immunoprecise Antibodies Demand Trend
Check current 90 days Immunoprecise Antibodies correlation with market (DOW)

Immunoprecise Beta

    
  1.01  
Immunoprecise standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.72  
It is essential to understand the difference between upside risk (as represented by Immunoprecise Antibodies's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Immunoprecise Antibodies stock's daily returns or price. Since the actual investment returns on holding a position in Immunoprecise Antibodies stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Immunoprecise Antibodies.

Immunoprecise Antibodies Implied Volatility

    
  284.64  
Immunoprecise Antibodies' implied volatility exposes the market's sentiment of Immunoprecise Antibodies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Immunoprecise Antibodies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Immunoprecise Antibodies stock will not fluctuate a lot when Immunoprecise Antibodies' options are near their expiration.

Immunoprecise Antibodies Stock Volatility Analysis

Volatility refers to the frequency at which Immunoprecise Antibodies stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Immunoprecise Antibodies' price changes. Investors will then calculate the volatility of Immunoprecise Antibodies' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Immunoprecise Antibodies' volatility:

Historical Volatility

This type of stock volatility measures Immunoprecise Antibodies' fluctuations based on previous trends. It's commonly used to predict Immunoprecise Antibodies' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Immunoprecise Antibodies' current market price. This means that the stock will return to its initially predicted market price.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Immunoprecise Antibodies Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
.

Immunoprecise Antibodies Projected Return Density Against Market

Considering the 90-day investment horizon the stock has the beta coefficient of 1.0079 . This usually indicates Immunoprecise Antibodies market returns are sensitive to returns on the market. As the market goes up or down, Immunoprecise Antibodies is expected to follow.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunoprecise Antibodies or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunoprecise Antibodies stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunoprecise stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has an alpha of 0.2311, implying that it can generate a 0.23 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 
Immunoprecise Antibodies' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how Immunoprecise Antibodies stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Company's Stock Price Volatility?

Several factors can influence a company's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Immunoprecise Antibodies Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunoprecise Antibodies or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunoprecise Antibodies stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunoprecise stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Considering the 90-day investment horizon the coefficient of variation of Immunoprecise Antibodies is 2153.9. The daily returns are distributed with a variance of 22.24 and standard deviation of 4.72. The mean deviation of Immunoprecise Antibodies is currently at 3.63. For similar time horizon, the selected benchmark (DOW) has volatility of 1.37
α
Alpha over DOW
0.23
β
Beta against DOW1.01
σ
Overall volatility
4.72
Ir
Information ratio 0.0488

Immunoprecise Antibodies Stock Return Volatility

Immunoprecise Antibodies historical daily return volatility represents how much Immunoprecise Antibodies stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The company has volatility of 4.7162% on return distribution over 90 days investment horizon. By contrast, DOW inherits 1.3427% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About Immunoprecise Antibodies Volatility

Volatility is a rate at which the price of Immunoprecise Antibodies or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Immunoprecise Antibodies may increase or decrease. In other words, similar to Immunoprecise's beta indicator, it measures the risk of Immunoprecise Antibodies and helps estimate the fluctuations that may happen in a short period of time. So if prices of Immunoprecise Antibodies fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2022
Market Capitalization148.5 M147.6 M
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing B cell sorting, screening, and sequencing custom, immune, and naive phage display production and screening transgenic animals and multi-species antibody discovery bi-specific, tri-specific, VHH, and VNAR antibody manufacturing DNA cloning, protein and antibody downstream processing antibody characterization on label-free biosensors and antibody engineering transient and stable cell line generation antibody optimization and humanization hybridoma production with multiplexed, high-throughput screening, and clone-picking and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Nearest Immunoprecise long CALL Option Payoff at Expiration

Immunoprecise Antibodies' implied volatility is one of the determining factors in the pricing options written on Immunoprecise Antibodies. Implied volatility approximates the future value of Immunoprecise Antibodiesusing the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Immunoprecise Antibodies over a specific time period.
View All Immunoprecise options
2022-06-17 CALL at $5.0 is a CALL option contract on Immunoprecise Antibodies' common stock with a strick price of 5.0 expiring on 2022-06-17. The contract was last traded on 2022-05-26 at 14:33:03 for $0.7 and, as of today, has 20 days remaining before the expiration. The option is currently trading at a bid price of $0.55, and an ask price of $0.75. The implied volatility as of the 28th of May is 98.7421.
 Profit 
Share
      Immunoprecise Antibodies Price At Expiration 

Immunoprecise Antibodies Investment Opportunity

Immunoprecise Antibodies has a volatility of 4.72 and is 3.52 times more volatile than DOW. 40  of all equities and portfolios are less risky than Immunoprecise Antibodies. Compared to the overall equity markets, volatility of historical daily returns of Immunoprecise Antibodies is lower than 40 () of all global equities and portfolios over the last 90 days. Use Immunoprecise Antibodies to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Immunoprecise Antibodies to be traded at $5.09 in 90 days. . Let's try to break down what Immunoprecise's beta means in this case. Immunoprecise Antibodies returns are very sensitive to returns on the market. As the market goes up or down, Immunoprecise Antibodies is expected to follow.

Modest diversification

The correlation between Immunoprecise Antibodies and DJI is Modest diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunoprecise Antibodies and DJI in the same portfolio, assuming nothing else is changed.

Immunoprecise Antibodies Additional Risk Indicators

The analysis of Immunoprecise Antibodies' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Immunoprecise Antibodies' investment and either accepting that risk or mitigating it. Along with some common measures of Immunoprecise Antibodies stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance0.0765
Market Risk Adjusted Performance0.2381
Mean Deviation3.7
Semi Deviation3.98
Downside Deviation4.13
Coefficient Of Variation1973.85
Standard Deviation4.74
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Immunoprecise Antibodies Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Sentinelone Inc vs. Immunoprecise Antibodies
Meta Platforms vs. Immunoprecise Antibodies
Walker Dunlop vs. Immunoprecise Antibodies
Visa vs. Immunoprecise Antibodies
COSCO SHIPPING vs. Immunoprecise Antibodies
Vmware vs. Immunoprecise Antibodies
FUJIAN AONONG vs. Immunoprecise Antibodies
Citigroup vs. Immunoprecise Antibodies
BANK OF NINGBO vs. Immunoprecise Antibodies
Microsoft Corp vs. Immunoprecise Antibodies
Atlassian Cls vs. Immunoprecise Antibodies
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Immunoprecise Antibodies as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Immunoprecise Antibodies' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Immunoprecise Antibodies' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Immunoprecise Antibodies.
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.